[Form 4] Incyte Genomics Inc Insider Trading Activity
Sheila A. Denton, EVP & General Counsel of Incyte Corp. (INCY), reported insider option activity under a written trading plan. The report shows Denton exercised 277 employee stock options with a $64.25 exercise price and simultaneously sold 277 shares at $86.81, leaving her beneficial ownership around 33,200 shares when including unvested restricted stock and performance units. The filing indicates an affirmative-defense trading plan consistent with Rule 10b5-1 and discloses remaining employee option holdings that become exercisable/vest under previously reported schedules.
Sheila A. Denton, EVP e General Counsel di Incyte Corp. (INCY), ha segnalato operazioni su opzioni da insider nell'ambito di un piano di negoziazione scritto. La comunicazione indica che Denton ha esercitato 277 opzioni azionarie dei dipendenti al prezzo di esercizio di 64,25 dollari e ha contestualmente venduto 277 azioni a 86,81 dollari, mantenendo una partecipazione beneficiaria di circa 33.200 azioni includendo azioni vincolate non ancora maturate e unit脿 basate sulla performance. Il deposito dichiara un piano di difesa affermativa conforme alla Rule 10b5-1 e rende noto il residuo delle opzioni dipendenti che diventeranno esercitabili/vest secondo i programmi precedentemente riportati.
Sheila A. Denton, EVP y Asesora General de Incyte Corp. (INCY), inform贸 actividad sobre opciones de insider bajo un plan de negociaci贸n por escrito. El informe muestra que Denton ejerci贸 277 opciones de acciones de empleados a un precio de ejercicio de 64,25 d贸lares y vendi贸 simult谩neamente 277 acciones a 86,81 d贸lares, manteniendo una participaci贸n beneficiaria de alrededor de 33.200 acciones al incluir acciones restringidas no devengadas y unidades por desempe帽o. La presentaci贸n indica un plan de negociaci贸n con defensa afirmativa conforme a la Regla 10b5-1 y revela las opciones de empleado restantes que se volver谩n ejercitables/vest seg煤n los calendarios informados previamente.
Sheila A. Denton, 鞚胳偓鞚错姼(Incyte Corp., INCY) 攵�靷灔 瓴� 齑濌磩氩曤毂呾瀯鞛愲姅 靹滊┐ 瓯半灅瓿勴殟鞐� 霐半澕 雮措秬鞛� 鞓奠厴 瓯半灅毳� 鞁犼碃頄堨姷雼堧嫟. 氤搓碃靹滌棎 霐半ゴ氅� Denton鞚� 頄夓偓臧� 64.25雼煬鞚� 歆侅洂 鞀ろ啞鞓奠厴 277欤茧ゼ 頄夓偓頃橁碃 霃欖嫓鞐� 277欤茧ゼ 欤茧嫻 86.81雼煬鞐� 毵る弰頄堨溂氅�, 牍勳垬霠� 鞝滍暅欤检檧 靹标臣 雼渼毳� 韽暔頃� 鞎� 33,200欤� 臧�霟夓潣 鞁れ 氤挫湢 歆�攵勳潉 鞙犾頃橁碃 鞛堨姷雼堧嫟. 鞝滌稖靹滊電� Rule 10b5-1鞐� 攵�頃╉晿電� 頇曤嫷氚╈柎(affirmative-defense) 瓯半灅瓿勴殟鞚� 氇呾嫓頃橁碃 鞛堨溂氅�, 鞚挫爠鞐� 氤搓碃霅� 鞚检爼鞐� 霐半澕 頄ロ泟 頄夓偓/氩犾姢韸鸽悹 雮潃 歆侅洂 鞓奠厴 氤挫湢霃� 瓿店皽頃橁碃 鞛堨姷雼堧嫟.
Sheila A. Denton, EVP et conseill猫re g茅n茅rale d'Incyte Corp. (INCY), a d茅clar茅 des op茅rations sur options d'initi茅s dans le cadre d'un plan de n茅gociation 茅crit. Le rapport indique que Denton a exerc茅 277 options d'achat d'actions attribu茅es aux employ茅s au prix d'exercice de 64,25 $ et a simultan茅ment vendu 277 actions 脿 86,81 $, conservant une participation b茅n茅ficiaire d'environ 33 200 actions en incluant les actions restreintes non acquises et les unit茅s de performance. Le d茅p么t pr茅cise un plan de n茅gociation 脿 d茅fense affirmative conforme 脿 la r猫gle 10b5-1 et divulgue les options employ茅s restantes qui deviendront exer莽ables/vest茅es selon les calendriers pr茅c茅demment d茅clar茅s.
Sheila A. Denton, EVP und General Counsel von Incyte Corp. (INCY), meldete Insider-Optionsgesch盲fte im Rahmen eines schriftlichen Handelsplans. Der Bericht zeigt, dass Denton 277 Mitarbeiter-Aktienoptionen zum Aus眉bungspreis von 64,25 USD ausge眉bt und gleichzeitig 277 Aktien zu 86,81 USD verkauft hat, wodurch ihre wirtschaftliche Beteiligung einschlie脽lich unverfallbarer Restricted Stocks und Performance-Einheiten bei rund 33.200 Aktien liegt. Die Einreichung weist auf einen Affirmative-Defense-Handelsplan gem盲脽 Rule 10b5-1 hin und legt die verbleibenden Mitarbeiteroptionsbest盲nde offen, die gem盲脽 zuvor gemeldeten Zeitpl盲nen aus眉bbar/vesten werden.
- None.
- None.
Insights
TL;DR: Routine insider option exercise and sale under a 10b5-1 plan; small net change in beneficial ownership.
The transaction reflects an executive exercising 277 options at a $64.25 strike and selling the same number of shares at $86.81, a simple exercise-and-sell that realized the spread. Beneficial ownership after the trades is reported at ~33,200 shares, which includes a material amount (32,544 shares) of unvested restricted stock units and performance units. On its face this is routine compensation-related activity rather than a strategic corporate event; it does not alter the company capital structure materially.
TL;DR: Disclosure follows Section 16 and notes a 10b5-1 trading plan; no governance red flags apparent from the filing.
The form is filed by the reporting person through an attorney-in-fact and explicitly checks that the trade was made pursuant to a written plan intended to satisfy Rule 10b5-1(c). The filing also explains the composition of shares that remain subject to vesting and the installment vesting schedule for earlier option grants. There are no indications of undisclosed related-party transactions or departures from standard Section 16 reporting practices.
Sheila A. Denton, EVP e General Counsel di Incyte Corp. (INCY), ha segnalato operazioni su opzioni da insider nell'ambito di un piano di negoziazione scritto. La comunicazione indica che Denton ha esercitato 277 opzioni azionarie dei dipendenti al prezzo di esercizio di 64,25 dollari e ha contestualmente venduto 277 azioni a 86,81 dollari, mantenendo una partecipazione beneficiaria di circa 33.200 azioni includendo azioni vincolate non ancora maturate e unit脿 basate sulla performance. Il deposito dichiara un piano di difesa affermativa conforme alla Rule 10b5-1 e rende noto il residuo delle opzioni dipendenti che diventeranno esercitabili/vest secondo i programmi precedentemente riportati.
Sheila A. Denton, EVP y Asesora General de Incyte Corp. (INCY), inform贸 actividad sobre opciones de insider bajo un plan de negociaci贸n por escrito. El informe muestra que Denton ejerci贸 277 opciones de acciones de empleados a un precio de ejercicio de 64,25 d贸lares y vendi贸 simult谩neamente 277 acciones a 86,81 d贸lares, manteniendo una participaci贸n beneficiaria de alrededor de 33.200 acciones al incluir acciones restringidas no devengadas y unidades por desempe帽o. La presentaci贸n indica un plan de negociaci贸n con defensa afirmativa conforme a la Regla 10b5-1 y revela las opciones de empleado restantes que se volver谩n ejercitables/vest seg煤n los calendarios informados previamente.
Sheila A. Denton, 鞚胳偓鞚错姼(Incyte Corp., INCY) 攵�靷灔 瓴� 齑濌磩氩曤毂呾瀯鞛愲姅 靹滊┐ 瓯半灅瓿勴殟鞐� 霐半澕 雮措秬鞛� 鞓奠厴 瓯半灅毳� 鞁犼碃頄堨姷雼堧嫟. 氤搓碃靹滌棎 霐半ゴ氅� Denton鞚� 頄夓偓臧� 64.25雼煬鞚� 歆侅洂 鞀ろ啞鞓奠厴 277欤茧ゼ 頄夓偓頃橁碃 霃欖嫓鞐� 277欤茧ゼ 欤茧嫻 86.81雼煬鞐� 毵る弰頄堨溂氅�, 牍勳垬霠� 鞝滍暅欤检檧 靹标臣 雼渼毳� 韽暔頃� 鞎� 33,200欤� 臧�霟夓潣 鞁れ 氤挫湢 歆�攵勳潉 鞙犾頃橁碃 鞛堨姷雼堧嫟. 鞝滌稖靹滊電� Rule 10b5-1鞐� 攵�頃╉晿電� 頇曤嫷氚╈柎(affirmative-defense) 瓯半灅瓿勴殟鞚� 氇呾嫓頃橁碃 鞛堨溂氅�, 鞚挫爠鞐� 氤搓碃霅� 鞚检爼鞐� 霐半澕 頄ロ泟 頄夓偓/氩犾姢韸鸽悹 雮潃 歆侅洂 鞓奠厴 氤挫湢霃� 瓿店皽頃橁碃 鞛堨姷雼堧嫟.
Sheila A. Denton, EVP et conseill猫re g茅n茅rale d'Incyte Corp. (INCY), a d茅clar茅 des op茅rations sur options d'initi茅s dans le cadre d'un plan de n茅gociation 茅crit. Le rapport indique que Denton a exerc茅 277 options d'achat d'actions attribu茅es aux employ茅s au prix d'exercice de 64,25 $ et a simultan茅ment vendu 277 actions 脿 86,81 $, conservant une participation b茅n茅ficiaire d'environ 33 200 actions en incluant les actions restreintes non acquises et les unit茅s de performance. Le d茅p么t pr茅cise un plan de n茅gociation 脿 d茅fense affirmative conforme 脿 la r猫gle 10b5-1 et divulgue les options employ茅s restantes qui deviendront exer莽ables/vest茅es selon les calendriers pr茅c茅demment d茅clar茅s.
Sheila A. Denton, EVP und General Counsel von Incyte Corp. (INCY), meldete Insider-Optionsgesch盲fte im Rahmen eines schriftlichen Handelsplans. Der Bericht zeigt, dass Denton 277 Mitarbeiter-Aktienoptionen zum Aus眉bungspreis von 64,25 USD ausge眉bt und gleichzeitig 277 Aktien zu 86,81 USD verkauft hat, wodurch ihre wirtschaftliche Beteiligung einschlie脽lich unverfallbarer Restricted Stocks und Performance-Einheiten bei rund 33.200 Aktien liegt. Die Einreichung weist auf einen Affirmative-Defense-Handelsplan gem盲脽 Rule 10b5-1 hin und legt die verbleibenden Mitarbeiteroptionsbest盲nde offen, die gem盲脽 zuvor gemeldeten Zeitpl盲nen aus眉bbar/vesten werden.
FAQ
What did INCY insider Sheila Denton do according to the Form 4?
How many shares does Sheila Denton beneficially own after the reported transactions?
Does the Form 4 indicate the trades were pre-planned?
How many shares are included as unvested restricted stock or performance units?
Are there remaining options or derivatives after the reported exercise?
